Skip to main content
Premium Trial:

Request an Annual Quote

David Henner, David Craford, Heino von Prondzynski, Werner Brandt, Franz Wirtz, Heinrich Hornef

Premium
Pathwork Diagnostics has appointed David Henner chief medical officer and has named David Craford vice president of commercial operations.
 
Henner formerly was vice president of oncology at Novacea and Craford was vice president of business development at Affymetrix.
 

 
Qiagen has nominated Heino von Prondzynski and Werner Brandt to the company’s supervisory board. They will stand for election at Qiagen’s annual meeting June 20.
 
Also at that meeting, Franz Wirtz and Heinrich Hornef will retire from their long-held positions on the company’s supervisory board. 
 
Prondzynski was CEO of Roche Diagnostics and a member of Roche’s executive committee and was CEO and general manager at Chiron.
 
Brandt has been chief financial officer at SAP since 2001 and was a member of SAP’s executive board. He also was CFO of Frenesius Medical Care and formerly worked in finance at Price Waterhouse Coopers.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more